A novel mechanism of sequestering fibroblast growth factor 2 by glypican in lipid rafts, allowing skeletal muscle differentiation

Molecular and Cellular Biology

Volumn 30, Issue 7, 2010, Pages 1634-1649

  Gutiérrez, Jaime ^a   Brandan, Enrique ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 2 RECEPTOR; FIBROBLAST GROWTH FACTOR 4; GLYPICAN; GROWTH FACTOR RECEPTOR; MYOGENIN; MYOSIN; SYNDECAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; LIPID RAFT; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 2; GLYPICANS; LAMININ; MEMBRANE MICRODOMAINS; MICE; MUSCLE, SKELETAL; MYOBLASTS; MYOGENIN; RATS; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION;

RATTUS;

EID: 77949381392     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01164-09     Document Type: Article

References (90)

1. Akiyama, S., T. Katagiri, M. Namiki, N. Yamaji, N. Yamamoto, K. Miyama, H. Shibuya, N. Ueno, J. M. Wozney, and T. Suda. 1997. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts. Exp. Cell Res. 235: 362-369.
2. Anastasi, S., S. Giordano, O. Sthandier, G. Gambarotta, R. Maione, P. Comoglio, and P. Amati. 1997. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation. J. Cell Biol. 137: 1057-1068.
3. Ashikari, S., H. Habuchi, and K. Kimata. 1995. Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor. J. Biol. Chem. 270: 29586-29593.
4. Beer, C., L. Pedersen, and M. Wirth. 2005. Amphotropic murine leukaemia virus envelope protein is associated with cholesterol-rich microdomains. Virol. J. 2: 36.
5. Bernfield, M., M. Gotte, P. W. Park, O. Reizes, M. L. Fitzgerald, J. Lincecum, and M. Zako. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68: 729-777.
6. Bernfield, M., and R. D. Sanderson. 1990. Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors. Philos. Trans. R. Soc. Lond. B Biol. Sci. 327: 171-186.
7. Brady, J. D., T. C. Rich, X. Le, K. Stafford, C. J. Fowler, L. Lynch, J. W. Karpen, R. L. Brown, and J. R. Martens. 2004. Functional role of lipid raft microdomains in cyclic nucleotide-gated channel activation. Mol. Pharmacol. 65: 503-511.
8. Brandan, E., D. J. Carey, J. Larrain, F. Melo, and A. Campos. 1996. Synthesis and processing of glypican during differentiation of skeletal muscle cells. Eur. J. Cell Biol. 71: 170-176.
9. Brandan, E., and J. Larraín. 1998. Heparan sulfate proteoglycans during terminal skeletal muscle cell differentiation: possible functions and regulation of their expression. Basic Appl. Myol. 8: 107-114.
10. Brandan, E., M. Maldonado, J. Garrido, and N. C. Inestrosa. 1985. Anchorage of collagen-tailed acetylcholinesterase to the extracellular matrix is mediated by heparan sulfate proteoglycans. J. Cell Biol. 101: 985-992.
11. Brown, D. 1994. GPI-anchored proteins and detergent-resistant membrane domains. Braz. J. Med. Biol. Res. 27: 309-315.
12. Brown, D. A., and E. London. 1998. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14: 111-136.
13. Brunetti, A., and I. D. Goldfine. 1990. Role of myogenin in myoblast differentiation and its regulation by fibroblast growth factor. J. Biol. Chem. 265: 5960-5963.
14. Campos, A., R. Nunez, C. S. Koenig, D. J. Carey, and E. Brandan. 1993. A lipid-anchored heparan sulfate proteoglycan is present in the surface of differentiated skeletal muscle cells. Isolation and biochemical characterization. Eur. J. Biochem. 216: 587-595.
15. Capurro, M. I., Y. Y. Xiang, C. Lobe, and J. Filmus. 2005. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res. 65: 6245-6254.
16. Capurro, M. I., P. Xu, W. Shi, F. Li, A. Jia, and J. Filmus. 2008. Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. Dev. Cell 14: 700-711.
17. Casar, J. C., C. Cabello-Verrugio, H. Olguin, R. Aldunate, N. C. Inestrosa, and E. Brandan. 2004. Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation. J. Cell Sci. 117: 73-84.
18. Catlow, K. R., J. A. Deakin, Z. Wei, M. Delehedde, D. G. Fernig, E. Gherardi, J. T. Gallagher, M. S. Pavao, and M. Lyon. 2008. Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density. J. Biol. Chem. 283: 5235-5248.
19. Chernousov, M. A., and D. J. Carey. 1993. N-syndecan (syndecan 3) from neonatal rat brain binds basic fibroblast growth factor. J. Biol. Chem. 268: 16810-16814.
20. Choi, S. C., S. J. Kim, J. H. Choi, C. Y. Park, W. J. Shim, and D. S. Lim. 2008. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Stem Cells Dev. 17: 725-736.
21. Cornelison, D., M. Filla, H. Stanley, A. Rapraeger, and B. Olwin. 2001. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev. Biol. 239: 79-94.
22. Cornelison, D., and B. Wold. 1997. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 191: 270-283.
23. Cornelison, D. D., B. B. Olwin, M. A. Rudnicki, and B. J. Wold. 2000. MyoD(-/-) satellite cells in single-fiber culture are differentiation defective and MRF4 deficient. Dev. Biol. 224: 122-137.
24. Cornelison, D. D., S. A. Wilcox-Adelman, P. F. Goetinck, H. Rauvala, A. C. Rapraeger, and B. B. Olwin. 2004. Essential and separable roles for Syndecan-3 and Syndecan-4 in skeletal muscle development and regeneration. Genes Dev. 18: 2231-2236.
25. Couchman, J. R. 2003. Syndecans: proteoglycan regulators of cell-surface microdomains? Nat. Rev. Mol. Cell Biol. 4: 926-937.
26. Droguett, R., C. Cabello-Verrugio, C. Riquelme, and E. Brandan. 2006. Extracellular proteoglycans modifies TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix Biol. 25: 332-341.
27. Fico, A., F. Maina, and R. Dono. 18 December 2007, posting date. Fine-tuning of cell signalling by glypicans. Cell. Mol. Life Sci. [Epub ahead of print.]
28. Filla, M. S., P. Dam, and A. C. Rapraeger. 1998. The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity. J. Cell. Physiol. 174: 310-321.
29. Filmus, J., and M. Capurro. 2008. The role of glypican-3 in the regulation of body size and cancer. Cell Cycle 7: 2787-2790.
30. Filmus, J., and S. B. Selleck. 2001. Glypicans: proteoglycans with a surprise. J. Clin. Investig. 108: 497-501.
31. Fransson, L. A. 2003. Glypicans. Int. J. Biochem. Cell Biol. 35: 125-129.
32. Fuentealba, L., D. J. Carey, and E. Brandan. 1999. Antisense inhibition of syndecan-3 expression during skeletal muscle differentiation accelerates myogenesis through a basic fibroblast growth factor-dependent mechanism. J. Biol. Chem. 274: 37876-37884.
33. Galbiati, F., D. Volonte, J. A. Engelman, P. E. Scherer, and M. P. Lisanti. 1999. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J. Biol. Chem. 274: 30315-30321.
34. García-Olivas, R., J. Hoebeke, S. Castel, M. Reina, G. Fager, F. Lustig, and S. Vilaro. 2003. Differential binding of platelet-derived growth factor isoforms to glycosaminoglycans. Histochem. Cell Biol. 120: 371-382.
35. García-Olivas, R., S. Vilaro, M. Reina, and S. Castel. 2007. PDGF-stimulated cell proliferation and migration of human arterial smooth muscle cells. Colocalization of PDGF isoforms with glycosaminoglycans. Int. J. Biochem. Cell Biol. 39: 1915-1929.
36. Gutierrez, J., N. Osses, and E. Brandan. 2006. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2. J. Cell. Physiol. 206: 58-67.
37. Hartung, A., K. Bitton-Worms, M. M. Rechtman, V. Wenzel, J. H. Boergermann, S. Hassel, Y. I. Henis, and P. Knaus. 2006. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol. Cell. Biol. 26: 7791-7805.
38. Hering, H., C. C. Lin, and M. Sheng. 2003. Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J. Neurosci. 23: 3262-3271.
39. Itoh, N., T. Mima, and T. Mikawa. 1996. Loss of fibroblast growth factor receptors is necessary for terminal differentiation of embryonic limb muscle. Development 122: 291-300.
40. Jenniskens, G. J., J. H. Veerkamp, and T. H. van Kuppevelt. 2006. Heparan sulfates in skeletal muscle development and physiology. J. Cell. Physiol. 206: 283-294.
41. Kwiatkowski, B. A., I. Kirillova, R. E. Richard, D. Israeli, and Z. Yablonka-Reuveni. 2008. FGFR4 and its novel splice form in myogenic cells: Interplay of glycosylation and tyrosine phosphorylation. J. Cell. Physiol. 215: 803-817.
42. Larraín, J., D. J. Carey, and E. Brandan. 1998. Syndecan-1 expression inhibits myoblast differentiation through a basic fibroblast growth factor-dependent mechanism. J. Biol. Chem. 273: 32288-32296.
43. Larrain, J., G. Cizmeci-Smith, V. Troncoso, R. C. Stahl, D. J. Carey, and E. Brandan. 1997. Syndecan-1 expression is down-regulated during myoblast terminal differentiation. Modulation By growth factors and retinoic acid. J. Biol. Chem. 272: 18418-18424.
44. Le Roy, C., and J. L. Wrana. 2005. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol. 6: 112-126.
45. Liu, W., E. D. Litwack, M. J. Stanley, J. K. Langford, A. D. Lander, and R. D. Sanderson. 1998. Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions. J. Biol. Chem. 273: 22825-22832.
46. Lyon, M., J. A. Deakin, K. Mizuno, T. Nakamura, and J. T. Gallagher. 1994. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J. Biol. Chem. 269: 11216-11223.
47. Lyon, M., G. Rushton, and J. T. Gallagher. 1997. The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific. J. Biol. Chem. 272: 18000-18006.
48. Mansukhani, A., P. Dell'Era, D. Moscatelli, S. Kornbluth, H. Hanafusa, and C. Basilico. 1992. Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin. Proc. Natl. Acad. Sci. USA 89: 3305-3309.
49. Massagué, J., S. Cheifetz, T. Endo, and B. Nadal-Ginard. 1986. Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. USA 83: 8206-8210.
50. McQuade, K. J., and A. C. Rapraeger. 2003. Syndecan-1 transmembrane and extracellular domains have unique and distinct roles in cell spreading. J. Biol. Chem. 278: 46607-46615.
51. Melo, F., D. J. Carey, and E. Brandan. 1996. Extracellular matrix is required for skeletal muscle differentiation but not myogenin expression. J. Cell. Biochem. 62: 227-239.
52. Midorikawa, Y., S. Ishikawa, H. Iwanari, T. Imamura, H. Sakamoto, K. Miyazono, T. Kodama, M. Makuuchi, and H. Aburatani. 2003. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int. J. Cancer 103: 455-465.
53. Mohammadi, M., S. K. Olsen, and O. A. Ibrahimi. 2005. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 16: 107-137.
54. Olguin, H., and E. Brandan. 2001. Expression and localization of proteoglycans during limb myogenic activation. Dev. Dyn. 221: 106-115.
55. Olwin, B. B., and A. Rapraeger. 1992. Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate. J. Cell Biol. 118: 631-639.
56. Ornitz, D. M., J. Xu, J. S. Colvin, D. G. McEwen, C. A. MacArthur, F. Coulier, G. Gao, and M. Goldfarb. 1996. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271: 15292-15297.
57. Osses, N., and E. Brandan. 2002. ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression. Am. J. Physiol. Cell Physiol. 282: C383-C394.
58. Osterholm, C., M. M. Barczyk, M. Busse, M. Gronning, R. K. Reed, and M. Kusche-Gullberg. 2009. Mutation in the heparan sulfate biosynthesis enzyme EXT1 influences growth factor signaling and fibroblast interactions with the extracellular matrix. J. Biol. Chem. 284: 34935-34943.
59. Ostermeyer, A. G., B. T. Beckrich, K. A. Ivarson, K. E. Grove, and D. A. Brown. 1999. Glycosphingolipids are not essential for formation of detergent-resistant membrane rafts in melanoma cells. Methyl-beta-cyclodextrin does not affect cell surface transport of a GPI-anchored protein. J. Biol. Chem. 274: 34459-34466.
60. Patel, S. G., P. E. Funk, and J. X. DiMario. 1999. Regulation of avian fibroblast growth factor receptor 1 (FGFR-1) gene expression during skeletal muscle differentiation. Gene 237: 265-276.
61. Pellegrini, L. 2001. Role of heparan sulfate in fibroblast growth factor signalling: a structural view. Curr. Opin. Struct. Biol. 11: 629-634.
62. Peng, H., H. Xie, S. Rossi, and R. Rotundo. 1999. Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J. Cell Biol. 145: 911-921.
63. Plotnikov, A. N., J. Schlessinger, S. R. Hubbard, and M. Mohammadi. 1999. Structural basis for FGF receptor dimerization and activation. Cell 98: 641-650.
64. Rapraeger, A. 2000. Syndecan-regulated receptor signaling. J. Cell Biol. 149: 995-998.
65. Rapraeger, A. C., A. Krufka, and B. B. Olwin. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252: 1705-1708.
66. Rider, C. C. 2006. Heparin/heparan sulphate binding in the TGF-beta cytokine superfamily. Biochem. Soc. Trans. 34: 458-460.
67. Riquelme, C., J. Larrain, E. Schonherr, J. P. Henriquez, H. Kresse, and E. Brandan. 2001. Antisense inhibition of decorin expression in myoblasts decreases cell responsiveness to transforming growth factor beta and accelerates skeletal muscle differentiation. J. Biol. Chem. 276: 3589-3596.
68. Rolny, C., D. Spillmann, U. Lindahl, and L. Claesson-Welsh. 2002. Heparin amplifies platelet-derived growth factor (PDGF)-BB-induced PDGF alpha-receptor but not PDGF beta-receptor tyrosine phosphorylation in heparan sulfate-deficient cells. Effects on signal transduction and biological responses. J. Biol. Chem. 277: 19315-19321.
69. Rudnicki, M. A., and R. Jaenisch. 1995. The MyoD family of transcription factors and skeletal myogenesis. Bioessays 17: 203-209.
70. Sabourin, L. A., and M. A. Rudnicki. 2000. The molecular regulation of myogenesis. Clin. Genet. 57: 16-25.
71. Schlessinger, J., A. N. Plotnikov, O. A. Ibrahimi, A. V. Eliseenkova, B. K. Yeh, A. Yayon, R. J. Linhardt, and M. Mohammadi. 2000. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6: 743-750.
72. Seale, P., and M. Rudnicki. 2000. A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev. Biol. 218: 115-124.
73. Seveau, S., H. Bierne, S. Giroux, M. C. Prevost, and P. Cossart. 2004. Role of lipid rafts in E-cadherin- and HGF-R/Met-mediated entry of Listeria monocytogenes into host cells. J. Cell Biol. 166: 743-753.
74. Sheehan, S., and R. Allen. 1999. Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor. J. Cell. Physiol. 181: 499-506.
75. Shi, Y., and J. Massague. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700.
76. Song, H. H., W. Shi, and J. Filmus. 1997. OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2. J. Biol. Chem. 272: 7574-7577.
77. Spizz, G., J. S. Hu, and E. N. Olson. 1987. Inhibition of myogenic differentiation by fibroblast growth factor or type beta transforming growth factor does not require persistent c-myc expression. Dev. Biol. 123: 500-507.
78. Steinfeld, R., H. Van Den Berghe, and G. David. 1996. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J. Cell Biol. 133: 405-416.
79. Stetzkowski-Marden, F., K. Gaus, M. Recouvreur, A. Cartaud, and J. Cartaud. 2006. Agrin elicits membrane lipid condensation at sites of acetylcholine receptor clusters in C2C12 myotubes. J. Lipid Res. 47: 2121-2133.
80. Su, G., K. Meyer, C. D. Nandini, D. Qiao, S. Salamat, and A. Friedl. 2006. Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells. Am. J. Pathol. 168: 2014-2026.
81. Tkachenko, E., and M. Simons. 2002. Clustering induces redistribution of syndecan-4 core protein into raft membrane domains. J. Biol. Chem. 277: 19946-19951.
82. Tortorella, L. L., D. J. Milasincic, and P. F. Pilch. 2001. Critical proliferation-independent window for basic fibroblast growth factor repression of myogenesis via the p42/p44 MAPK signaling pathway. J. Biol. Chem. 276: 13709-13717.
83. Villena, J., C. Berndt, F. Granes, M. Reina, and S. Vilaro. 2003. Syndecan-2 expression enhances adhesion and proliferation of stably transfected Swiss 3T3 cells. Cell Biol. Int. 27: 1005-1010.
84. Yaffe, D., and O. Saxel. 1977. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727.
85. Yang, Y., M. Borset, J. K. Langford, and R. D. Sanderson. 2003. Heparan sulfate regulates targeting of syndecan-1 to a functional domain on the cell surface. J. Biol. Chem. 3: 3.
86. Yayon, A., M. Klagsbrun, J. D. Esko, P. Leder, and D. M. Ornitz. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848.
87. Yu, S., L. Zheng, D. K. Trinh, S. L. Asa, and S. Ezzat. 2004. Distinct transcriptional control and action of fibroblast growth factor receptor 4 in differentiating skeletal muscle cells. Lab. Investig. 84: 1571-1580.
88. Zhang, Y., J. Li, C. Partovian, F. W. Sellke, and M. Simons. 2003. Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo. Am. J. Physiol. Heart Circ. Physiol. 284: H2078-H2082.
89. Zhao, P., G. Caretti, S. Mitchell, W. L. McKeehan, A. L. Boskey, L. M. Pachman, V. Sartorelli, and E. P. Hoffman. 2006. Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway. J. Biol. Chem. 281: 429-438.
90. Zhu, D., W. C. Xiong, and L. Mei. 2006. Lipid rafts serve as a signaling platform for nicotinic acetylcholine receptor clustering. J. Neurosci. 26: 4841-4851.